Watch CBSN Live

AstraZeneca says trial data from U.S. study on its COVID-19 vaccine shows it's 79% effective

AstraZeneca says advanced trial data from a U.S. study on the COVID-19 vaccine it developed along with Oxford University shows it is 79% effective in preventing symptomatic illness and 100% effective against severe illness and hospitalization. Dr. David Agus joined "CBS This Morning" to explain more.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.